Al-Powered Precision: GE HealthCare's Vision for MedTech Innovation in India

GE HealthCare's CTO shares how AI-led innovations from India are redefining diagnostics, oncology, and access in the country's rapidly evolving MedTech landscape.

- Shrikanth G

India's MedTech sector is rapidly growing, fuelled by initiatives like the National Health Policy, Ayushman Bharat PM-JAY, and the Ayushman Bharat Digital Mission, which enhance healthcare access and delivery.

AI and ML are driving advancements, transforming diagnostics and treatment through preventive, predictive, and personalised care. Al adoption in Indian healthcare, valued at $1.6 billion by 2025, is robust, with 57% of providers using Al—outpacing global rates.

In a conversation with Dataquest, Girish Raghavan, CTO - Women's Health & X-Ray and VP - Engineering at GE HealthCare Technology Centre India, shares how GE HealthCare is driving India's MedTech evolution with advanced technologies and a commitment to 'Make in India, for the world.'

Their focus on Al-driven diagnostics, especially in oncology and imaging, aims to deliver precision health nationwide. Innovations like the AI-powered Cath Lab and Revolution Aspire CT enhance diagnosis and imaging intelligence. India stands as a critical market for their strategic mission towards creating a world where healthcare has no limits and enabling clinicians to diagnose patients accurately across diverse clinical environments. Excerpts.

How does India fit into GE HealthCare's global strategy, given its rapid MedTech growth?

Today, India is the fourth-largest economy in the world—a $4 trillion economy. India is not only among the world's fastest-growing economies but also among the top 20 MedTech markets globally. Reports suggest that India's global market share in medical devices is expected to grow from 1.65% to 10-12% over the next 25 years. These statistics make India a market of opportunities. The country is also ambitiously investing in healthcare and incentivising localisation. India's public expenditure on healthcare touched 2.1% of GDP in FY 23 and 2.2% in FY 22, up from 1.6% in FY 21 (as per the Economic Survey 2022-23).